Skip to main content
SpringerLink
Log in
Book cover

Tobacco pp 107–144Cite as

Treatment and the Role of the Physician

  • Chapter

  • 115 Accesses

Part of the book series: Drugs of Abuse ((DOAC,volume 4))

Abstract

Every year almost three-quarters of the nation’s 46 million smokers vow to stop. But very few do. In fact, those that can quit easily already have quit. And for those who keep trying, there is no shortage of programs available. There are a myriad of options, from proprietary ones like Smokenders to programs sponsored by nonprofit organizations and local groups such as the American Cancer Society and the YMCA.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Physician treatment of nicotine addiction. The Facts about Tobacco, Alcohol and Other Drugs, Vol. 3, No. 1, Winter 1994.

    Google Scholar 

  2. Smoking interventions: What you can do. Clinical Opportunities for Smoking Intervention: A Guide for the Busy Physician. U.S. Dept. of Health and Human Services, Public Health Service, National Institutes of Health, 1986.

    Google Scholar 

  3. Hearn W. Why don’t smokers quit? Am Med News. December 27,1993.

    Google Scholar 

  4. Glynn TJ, Manley MW. How to Help Your Patients Stop Smoking: A National Cancer Institute Manual for Physicians. Smoking and Tobacco Control Program, Division of Cancer Prevention and Control National Cancer Institute, 1992.

    Google Scholar 

  5. Slade J. Nicotine dependence: Intervention strategies for the physician. NJ Med. 1993;90(11):831–834.

    CAS  Google Scholar 

  6. Cocores JA. The clinical management of nicotine addiction. In Miller NS, ed., Handbook of Drug and Alcohol Addiction. New York: Marcel Dekker.

    Google Scholar 

  7. Fagerstrom KO. Toward better diagnoses and more individual treatment of tobacco dependence. Br J Addiction. 1991;86:543–547.

    Article  CAS  Google Scholar 

  8. Hollis JF, Lichtenstein E, Vogt TM et al. Nurse-assisted counseling for smokers in primary care. Ann Intern Med. 1993;118(7):521–525.

    PubMed  CAS  Google Scholar 

  9. Schwartz JL. Review and evaluation of smoking cessation methods: The United States and Canada, 1978–1985. U.S. Department of Health and Human Services. Public Health Services, National Institutes of Health. Washington, DC: Government Printing Office, 1987.

    Google Scholar 

  10. Mermelstein R, Cohen S, Lichtenstein E, et al. Social support and smoking cessation and maintenance. J Consult Clin Psychol. 1986; 54:447–453.

    Article  CAS  Google Scholar 

  11. Jarvik ME, Schneider NA. Nicotine. In Lowinstein JH, Ruiz P, Millman RB, eds., Substance Abuse: Comprehensive Textbook. Baltimore: Williams & Wilkins, 1992.

    Google Scholar 

  12. Hurt RD. Nicotine dependence-treatment for the 1990s. Editorial. J Intern Med. 1993;233:307–310.

    Article  PubMed  CAS  Google Scholar 

  13. U.S. Department of Health and Human Services. The Health Consequences of Smoking: A Report of the Surgeon General. Washington DC: Government Printing Office, 1988.

    Google Scholar 

  14. Raw M. The treatment of cigarette dependence. In Isreal Y, Glaser FB, Kalant H, Popham RE, Schmidt W, Smart RG, eds., Research Advances in Alcohol and Drug Problems. New York: Plenum Press, 1978.

    Google Scholar 

  15. Carmody TP. Preventing relapse in the treatment of nicotine addiction: Current issues and future directions. J Psychoactive Drugs. 1990; 22(2):211–238.

    Article  PubMed  CAS  Google Scholar 

  16. Russell MA. The future of nicotine replacement. Br J Addiction. 1991;86:653–658.

    Article  CAS  Google Scholar 

  17. Hughes JR, Hatsukami DK, Skoog KP. Physical dependence on nicotine in gum: A placebo substitution trial. JAMA. 1986;255:3277–3279.

    Article  PubMed  CAS  Google Scholar 

  18. Henningfield JE, Radzius A, Cooper TM et al. Drinking coffee and carbonated beverages blocks absorption of nicotine from nicotine polacrilex gum. JAMA. 1990;264:1560–1564.

    Article  PubMed  CAS  Google Scholar 

  19. Cummings S, Hansen B, Richard RJ et al. Internists and nicotine gum. JAMA. 1988;260:1565–1569

    Article  PubMed  CAS  Google Scholar 

  20. Schneider NG. Nicotine gum in smoking cessation: Rationale, efficacy, and proper use. Cormpr Ther. 1987;13:32–37.

    CAS  Google Scholar 

  21. Benowitz NL. Toxicity of nicotine: implications with regard to nicotine replacement therapy. In Pomerleau OF, Pomerleau CS, eds., Nicotine Replacement: A Critical Evaluation. New York: Liss, 1988.

    Google Scholar 

  22. Henningfield JE, London ED, Benowitz NL. Arterial-venous differences in plasma concentrations of nicotine after cigarette smoking. JAMA. 1990;263(15):2049–2050

    Article  PubMed  CAS  Google Scholar 

  23. Cox JL, McKenna JP. Nicotine gum: Does providing it free in smoking cessation program alter success rates? J Fam Pract. 1990;31(3):278–280.

    PubMed  CAS  Google Scholar 

  24. Research Committee of the British Thoracic Society. Smoking cessation in patients: Two further studies by the British Thoracic Society. Thorax. 1990;45:835–840.

    Article  Google Scholar 

  25. Schneider NG. How to Use Nicotine Gum and Other Strategies to Quit Smoking. New York: Simon & Schuster, 1988.

    Google Scholar 

  26. Hughes JR, Miller SA. Nicotine gum to help stop smoking. JAMA. 1984;2252:2855–2858.

    Article  Google Scholar 

  27. Jarvis, M. Nasal nicotine solution: Its potential in smoking cessation and as a research tool. In Ockene JK, ed., The Pharmacologic Treatment of Tobacco Dependence: Proceedings of the World Congress. Cambridge: Harvard Institute for the Study of Smoking Behavior and Policy, 1986.

    Google Scholar 

  28. Perkins KA, Grobe JE, Stilleer RL et al. Nasal spray nicotine replacement suppresses cigarette smoking desire and behavior. Clin Pharmacol Therapeut. 1992;52(6):627–634.

    Article  CAS  Google Scholar 

  29. Ornish SA, Zisook S, McAdams LA. Effects of transdermal clonidine treatment on withdrawal symptoms associated with smoking cessation. Arch Intern Med. 1988;148:2027–2031.

    Article  PubMed  CAS  Google Scholar 

  30. Jancin, B. Bupropion can help recidivist smokers quit, research shows. Clin Psychiatr News. February 1993.

    Google Scholar 

  31. Gritz ER, Jarvik ME. Pharmacological aids for the cessation of smoking. In Steinfeld J, Griffitths W, Ball K, Taylor R, eds., Proceedings of the 3rd World Conference on Smoking and Health. Washington, DC: U.S. DHEW, Public Health Service, 1977.

    Google Scholar 

  32. Sachs DPI. Cigarette smoking health effects and cessation strategies. Clin Geriatr Med. 1986;2:337–362.

    PubMed  CAS  Google Scholar 

  33. Spring B, Pingitore R, Kessler K. Strategies to minimize weight gain after smoking cessation: Psychological and pharmacological intervention with specific reference to dexfenfluramine. Inter J Obesity. 1992;16(Supp1.3):S19—S23.

    Google Scholar 

  34. Sutherland G, Russell MA, Stapleton JA et al. Glycerol particle cigarettes: A less harmful option for chronic smokers. Thorax. 1993;48: 385–387.

    Article  PubMed  CAS  Google Scholar 

  35. Kolonen S. Low-Yield Cigarettes: Smoke Exposure and Puffing Behaviour. Kuopio Finland: Kuopio University Publications, 1992.

    Google Scholar 

Additional Sources

  • Prochaska J, DiClemente CC, Norcross JC. In search of how people change. American Psychologist. 1992:1102–1114.

    Google Scholar 

  • Dalack GW, Glassman AH, Rivelli S et al. Mood, major depression, and fluoxetine response in cigarette smokers. Presented at New Research Poster Session at 145th Annual Meeting of the American Psychiatric Association, May 2–7,1992.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. University of Florida Brain Institute, Gainesville, Florida, USA

    Mark S. Gold M.D.

Authors
  1. Mark S. Gold M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 1995 Springer Science+Business Media New York

About this chapter

Cite this chapter

Gold, M.S. (1995). Treatment and the Role of the Physician. In: Tobacco. Drugs of Abuse, vol 4. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-1845-7_6

Download citation

  • DOI: https://doi.org/10.1007/978-1-4615-1845-7_6

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4613-5748-3

  • Online ISBN: 978-1-4615-1845-7

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation